Cagrilintide as a standalone medication is earlier in development, so an individual approval is likely further out, possibly 2028 or beyond
Legal Disclaimer This product is intended strictly for laboratory research purposes only
Digestive and Organ Protection: This peptide also has unique gastroprotective properties, helping heal and protect the stomach and intestines from inflammation, ulcers, and injury
[33] Disclaimer: These statements have not been evaluated by the Food and Drug Administration
After a single IV administration, BPC157 was rapidly eliminated from the plasma of rats, and the average elimination half-life (t 1/2 ) was 15.2 min
The salt content can interfere with peptide stability and cause precipitation in some cases